cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLCcardiovascular-1731Research ArticleМНЕНИЕ ПО ПРОБЛЕМЕOPINION ON A PROBLEMИзменятся ли наши взгляды на контроль частоты сердечных сокращений у больных стабильной стенокардией после исследования BEAUTIFUL?Will the BEAUTIFUL Study results change our views on heart rate control?ЛопатинЮ. М.LopatinYu. M.ljpatin@vlpost.ruВолгоградский государственный медицинский университет, Волгоградский областной кардиологический центр, г. ВолгоградVolgograd State Medical University, Volgograd Region Cardiology Center. Volgograd200820122008787074Copyright © Лопатин Ю.М., 20082008Лопатин Ю.М.Lopatin Y.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/1731стабильная стенокардияингибитор if каналовивабрадинstable anginaIf inhibitorivabradineReferencesWilhelmsen I, Berglung G, Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986; 7: 279-88.Wilhelmsen I, Berglung G, Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986; 7: 279-88.Palatini P, Casiglia E, Pauletto P. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects: results of the HARVEST trial. Circulation 1994; 90: 2870-2.Palatini P, Casiglia E, Pauletto P. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects: results of the HARVEST trial. Circulation 1994; 90: 2870-2.Diaz A, Bourassa GM, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967-74.Diaz A, Bourassa GM, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967-74.Hjalmarson A, Gilpin E, Kjekshus J, et al. Influence of heart rate onmortality after acute myocardial infarction. Am J Cardiol 1990; 65: 547-53.Hjalmarson A, Gilpin E, Kjekshus J, et al. Influence of heart rate onmortality after acute myocardial infarction. Am J Cardiol 1990; 65: 547-53.Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J 1999; 1(Suppl H): H64-9.Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J 1999; 1(Suppl H): H64-9.Poldermans D, Bax JJ, Schouten O, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? JACC 2006; 48: 964-9.Poldermans D, Bax JJ, Schouten O, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? JACC 2006; 48: 964-9.Beere PA, Glagov S, Zarins CR. Retarding effects of lowering heart rate on coronary atherosclerosis. Science 1984; 226: 180-2.Beere PA, Glagov S, Zarins CR. Retarding effects of lowering heart rate on coronary atherosclerosis. Science 1984; 226: 180-2.Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate associated with coronary plaque distruption. Circulation 2001; 104: 1477-82.Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate associated with coronary plaque distruption. Circulation 2001; 104: 1477-82.Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341-81.Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341-81.Диагностикаи лечение стабильной стенокардии. Российские рекомендации, второй пересмотр. Кардиоваскулярная терапия и профилактика. 2008; 7(6). Приложение 4.Диагностикаи лечение стабильной стенокардии. Российские рекомендации, второй пересмотр. Кардиоваскулярная терапия и профилактика. 2008; 7(6). Приложение 4.Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Long-term compliance with beta-blokers, angiotensin-converting enzyme inhibitors, and statins after myocardial infarction. Eur Heart J 2006; 27: 1153-8.Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Long-term compliance with beta-blokers, angiotensin-converting enzyme inhibitors, and statins after myocardial infarction. Eur Heart J 2006; 27: 1153-8.Daly CA, Clements F, Lopez Sendoz JL, et al. The initial management of stable angina in Europe, from the Euro Heart Survey. Eur Heart J 2005; 26: 1011-22.Daly CA, Clements F, Lopez Sendoz JL, et al. The initial management of stable angina in Europe, from the Euro Heart Survey. Eur Heart J 2005; 26: 1011-22.Daly CA, Clements F, Lopez Sendoz JL, et al. The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina. Eur Heart J 2006; 27: 1298-304.Daly CA, Clements F, Lopez Sendoz JL, et al. The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina. Eur Heart J 2006; 27: 1298-304.Daly C, Tavazzi L, Fox K, on behalf of Euro Heart Survey of Angina Investigators. Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey. Eur Heart J 2008; 29(Suppl): 204-5.Daly C, Tavazzi L, Fox K, on behalf of Euro Heart Survey of Angina Investigators. Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey. Eur Heart J 2008; 29(Suppl): 204-5.Vliegen HW, van der Wall EE, Niemeyer MG, et al. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris. J Cardiovasc Pharmacol 1991; 18 (Suppl. 9): S55-60.Vliegen HW, van der Wall EE, Niemeyer MG, et al. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris. J Cardiovasc Pharmacol 1991; 18 (Suppl. 9): S55-60.Fox K, Ford I, Steg PG, et al. on behalf of the BEAUTIFUL investigators. Ivabradine fro patients with stable coronary artery disease and left-ventricular dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet 2008; Published Online August 31, 2008.Fox K, Ford I, Steg PG, et al. on behalf of the BEAUTIFUL investigators. Ivabradine fro patients with stable coronary artery disease and left-ventricular dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet 2008; Published Online August 31, 2008.Fox K, Ford I, Steg PG, et al. on behalf of the BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial. Lancet 2008. Published Online August 31, 2008.Fox K, Ford I, Steg PG, et al. on behalf of the BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial. Lancet 2008. Published Online August 31, 2008.
The authors declare that there are no conflicts of interest present.